Locations:
Search
A new, precise biomarker for CV risk in psoriatic disease?
Disagreement on both sides of Atlantic about classic RCVS case
Q&A with leaders of a new research collaboration
Early focus will be selective TNF-α receptor inhibition
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
VERVE study aims for answers
Integrated care matters when lupus involves the kidneys
More takeaways from the Biologic Therapies VI Summit
Profiling biologics’ role in RA and psoriasis
Encouraging Pilot Study Paves Way for Randomized Trial
Better outcomes in psoriatric arthritis, lupus, Wegener’s
Advertisement
Advertisement